Literature DB >> 9715879

Characterisation of the cytotoxic alloresponse of cord blood.

C Barbey1, O Irion, C Helg, B Chapuis, C Grand, C Chizzolini, M Jeannet, E Roosnek.   

Abstract

As compared to bone marrow, transplantation with cord blood (CB) is associated with a lower risk of GVHD. Although some cases of GVHD III have been reported, usually the grade of GVHD remains low, even when donor and recipient are not fully HLA matched. To investigate whether this is due to an intrinsic property of CB T cells, we studied the conditions under which CB CD8+ cells would be able to generate an alloresponse. In addition, we measured the cytokines secreted by the alloreactive cytotoxic T lymphocyte (CTL) clones generated. We show that: (1) the capacity of CB cells to generate alloreactive CTLs in vitro is diminished as compared to adult cells (AB); (2) in the presence of exogenous IL-2, CB cells do generate a normal alloreactive response; (3) although CB-derived CD8+ allospecific clones showed the same T1/T0 cytokine profile as the clones from AB, they secreted a lower amount of IFN-gamma; and (4) in addition, cloned CD4+ CB cells are mainly T2/T0 type, whereas AB CD4+ T cells were mainly of T1/T0 type. These data suggest that the reduced GVHD observed after transplantation with CB might be the result of the naiveness of CB T cells. After allostimulation, CB cytotoxic T cells differ from AB T cells by a higher activation threshold, a lower secretion of IFN-gamma by both CD4+ and CD8+ CB cells and their bias towards a T2 type CD4 response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9715879

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

1.  Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.

Authors:  Lisa Marie Serrano; Timothy Pfeiffer; Simon Olivares; Tontanai Numbenjapon; Jennifer Bennitt; Daniel Kim; David Smith; George McNamara; Zaid Al-Kadhimi; Joseph Rosenthal; Stephen J Forman; Michael C Jensen; Laurence J N Cooper
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

2.  Induction of functional CD154 (CD40 ligand) in neonatal T cells by cAMP-elevating agents.

Authors:  A Suárez; L Mozo; A Gayo; A Simó; C Gutiérrez
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

Review 3.  T cell immunity in neonates.

Authors:  A M Garcia; S A Fadel; S Cao; M Sarzotti
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

4.  Is Infant Immunity Actively Suppressed or Immature?

Authors:  Ana L Gervassi; Helen Horton
Journal:  Virology (Auckl)       Date:  2014
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.